CN102258946A - 一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 - Google Patents
一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 Download PDFInfo
- Publication number
- CN102258946A CN102258946A CN2011101065033A CN201110106503A CN102258946A CN 102258946 A CN102258946 A CN 102258946A CN 2011101065033 A CN2011101065033 A CN 2011101065033A CN 201110106503 A CN201110106503 A CN 201110106503A CN 102258946 A CN102258946 A CN 102258946A
- Authority
- CN
- China
- Prior art keywords
- low
- haemodialysis
- density lipoprotein
- membrane material
- heparin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 73
- 239000000463 material Substances 0.000 title claims abstract description 51
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 41
- 102000007330 LDL Lipoproteins Human genes 0.000 title claims abstract description 35
- 108010007622 LDL Lipoproteins Proteins 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title abstract description 14
- 238000001179 sorption measurement Methods 0.000 title abstract description 11
- 230000000322 hemodialysis Effects 0.000 title abstract description 9
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229920000669 heparin Polymers 0.000 claims abstract description 48
- 229960002897 heparin Drugs 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 239000007789 gas Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011261 inert gas Substances 0.000 claims abstract description 6
- 239000007822 coupling agent Substances 0.000 claims abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 40
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 33
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 238000010521 absorption reaction Methods 0.000 claims description 20
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 238000009832 plasma treatment Methods 0.000 claims description 16
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 11
- 238000010168 coupling process Methods 0.000 claims description 11
- 238000005859 coupling reaction Methods 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 230000006641 stabilisation Effects 0.000 claims description 11
- 238000011105 stabilization Methods 0.000 claims description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 8
- 229920006393 polyether sulfone Polymers 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 229910052786 argon Inorganic materials 0.000 claims description 6
- 229920002492 poly(sulfone) Polymers 0.000 claims description 6
- 239000004695 Polyether sulfone Substances 0.000 claims description 5
- 239000001569 carbon dioxide Substances 0.000 claims description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
- 239000001307 helium Substances 0.000 claims description 5
- 229910052734 helium Inorganic materials 0.000 claims description 5
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000012510 hollow fiber Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 238000000926 separation method Methods 0.000 abstract description 7
- 238000005406 washing Methods 0.000 abstract description 6
- 230000004048 modification Effects 0.000 abstract description 4
- 238000012986 modification Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 229920002521 macromolecule Polymers 0.000 abstract description 2
- 238000000678 plasma activation Methods 0.000 abstract description 2
- 238000003672 processing method Methods 0.000 abstract description 2
- 230000010355 oscillation Effects 0.000 abstract 2
- 239000008055 phosphate buffer solution Substances 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000001291 vacuum drying Methods 0.000 description 18
- 238000007654 immersion Methods 0.000 description 14
- 239000002352 surface water Substances 0.000 description 9
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical class C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- -1 sulfuric acid dextran sodium salt Chemical class 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
实施例序号 | 聚合物膜材料 | 肝素固定化密度(微克/平方厘米) | 水接触角(°) |
1 | 聚砜 | 0.17 | 66 |
2 | 聚砜 | 0.45 | 54 |
3 | 聚砜 | 0.66 | 47 |
4 | 聚醚砜 | 0.38 | 56 |
5 | 聚醚砜 | 0.49 | 52 |
6 | 聚醚砜 | 0.77 | 43 |
7 | 聚丙烯腈 | 0.84 | 37 |
8 | 聚丙烯腈 | 0.93 | 32 |
9 | 聚丙烯腈 | 0.72 | 41 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110106503 CN102258946B (zh) | 2011-04-27 | 2011-04-27 | 一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110106503 CN102258946B (zh) | 2011-04-27 | 2011-04-27 | 一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102258946A true CN102258946A (zh) | 2011-11-30 |
CN102258946B CN102258946B (zh) | 2013-02-27 |
Family
ID=45005895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110106503 Active CN102258946B (zh) | 2011-04-27 | 2011-04-27 | 一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102258946B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877634A (zh) * | 2014-03-10 | 2014-06-25 | 石家庄达爱医疗器械科技有限公司 | 一种血液透析器及血液透析装置 |
CN105311974A (zh) * | 2014-07-31 | 2016-02-10 | 中国科学院大连化学物理研究所 | 一种具有高抗凝血性能血液透析膜及其制备方法 |
CN106422822A (zh) * | 2016-09-09 | 2017-02-22 | 江南大学 | 一种表面肝素化血液透析膜及其制备方法 |
CN107812253A (zh) * | 2017-11-17 | 2018-03-20 | 南通纺织丝绸产业技术研究院 | 一种肝素化丝素蛋白膜及其制备方法 |
CN110124628A (zh) * | 2018-02-02 | 2019-08-16 | 重庆希尔康血液净化器材研发有限公司 | 一种低密度脂蛋白吸附剂膜材料及时制备方法 |
CN115975238A (zh) * | 2023-02-10 | 2023-04-18 | 中南大学湘雅医院 | 乙二胺四乙酸改性膜式人工脏器材料及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006288866A (ja) * | 2005-04-13 | 2006-10-26 | Toyobo Co Ltd | 中空糸型血液浄化膜への表面改質剤コーティング方法、表面改質剤コート中空糸型血液浄化膜および表面改質剤コート中空糸型血液浄化器 |
EP1427532B1 (en) * | 2001-08-28 | 2007-02-14 | Porex Corporation | Multi-layer coated porous materials and methods of making the same |
CN101024150A (zh) * | 2007-01-12 | 2007-08-29 | 中国科学院上海有机化学研究所 | 一种表面固定肝素配基的多孔膜材料、制备方法和应用 |
CN101912771A (zh) * | 2010-08-20 | 2010-12-15 | 浙江大学 | 分子识别分离膜及其制备方法与应用 |
-
2011
- 2011-04-27 CN CN 201110106503 patent/CN102258946B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1427532B1 (en) * | 2001-08-28 | 2007-02-14 | Porex Corporation | Multi-layer coated porous materials and methods of making the same |
JP2006288866A (ja) * | 2005-04-13 | 2006-10-26 | Toyobo Co Ltd | 中空糸型血液浄化膜への表面改質剤コーティング方法、表面改質剤コート中空糸型血液浄化膜および表面改質剤コート中空糸型血液浄化器 |
CN101024150A (zh) * | 2007-01-12 | 2007-08-29 | 中国科学院上海有机化学研究所 | 一种表面固定肝素配基的多孔膜材料、制备方法和应用 |
CN101912771A (zh) * | 2010-08-20 | 2010-12-15 | 浙江大学 | 分子识别分离膜及其制备方法与应用 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877634A (zh) * | 2014-03-10 | 2014-06-25 | 石家庄达爱医疗器械科技有限公司 | 一种血液透析器及血液透析装置 |
CN105311974A (zh) * | 2014-07-31 | 2016-02-10 | 中国科学院大连化学物理研究所 | 一种具有高抗凝血性能血液透析膜及其制备方法 |
CN105311974B (zh) * | 2014-07-31 | 2018-11-13 | 中国科学院大连化学物理研究所 | 一种具有高抗凝血性能血液透析膜及其制备方法 |
CN106422822A (zh) * | 2016-09-09 | 2017-02-22 | 江南大学 | 一种表面肝素化血液透析膜及其制备方法 |
CN107812253A (zh) * | 2017-11-17 | 2018-03-20 | 南通纺织丝绸产业技术研究院 | 一种肝素化丝素蛋白膜及其制备方法 |
CN110124628A (zh) * | 2018-02-02 | 2019-08-16 | 重庆希尔康血液净化器材研发有限公司 | 一种低密度脂蛋白吸附剂膜材料及时制备方法 |
CN115975238A (zh) * | 2023-02-10 | 2023-04-18 | 中南大学湘雅医院 | 乙二胺四乙酸改性膜式人工脏器材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102258946B (zh) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102258946B (zh) | 一种低密度脂蛋白亲和吸附血液透析膜材料的制备方法 | |
CN101804307B (zh) | 抗凝血复合超滤膜及其制备方法 | |
TW200820999A (en) | Substrate and manufacturing method thereof | |
CN114106493B (zh) | 一种肝素化pvc材料、其制备方法及作为医疗器械的应用 | |
CN101602805B (zh) | 用于纯化手足口病免疫球蛋白的琼脂糖亲和介质及其制备方法 | |
CN109675134A (zh) | 一种血液透析器的抗凝改性方法及其应用 | |
CN106310970B (zh) | 一种用于血液透析的改性聚偏氟乙烯中空纤维膜 | |
CN102512973A (zh) | 一种低温等离子体接枝蛋白改性聚偏氟乙烯膜的制备方法 | |
JP2006291193A (ja) | 改質基材およびその製造方法 | |
CN201669064U (zh) | 抗凝血复合超滤膜 | |
CN111195485B (zh) | 一种聚氯乙烯血液净化膜制备方法 | |
CN113230898B (zh) | 一种体外循环抗凝血改性膜的制备方法 | |
CN104069743A (zh) | 一种表面两性离子化的聚乳酸血液透析膜的制备方法 | |
CN109316968A (zh) | 一种血液透析器用透析膜及其制备方法 | |
CN102743985B (zh) | 一种用于脱除内毒素的聚砜丝氨酸亲和膜的制备方法 | |
CN109794172B (zh) | 一种用于血液净化的抗菌中空纤维膜的制备方法 | |
Ma et al. | Heparin removal from blood using poly (L‐lysine) immobilized hollow fiber | |
CN111012959A (zh) | 一种医用材料及在其表面制备抗凝血涂层的方法 | |
CN109316986B (zh) | 一种丙烯酸和磺化二羟丙基壳聚糖改性聚砜膜及其制备方法 | |
CN114669282B (zh) | 一种内毒素吸附剂及其制备方法和应用 | |
JP2777604B2 (ja) | 体液処理用吸着材 | |
Hinrichs et al. | In vitro evaluation of heparinized Cuprophan hemodialysis membranes | |
CN101732765B (zh) | 生物型高交联网状缓释ecmo涂层材料及其制备方法与应用 | |
CN102172515B (zh) | 一种表面类肝素化聚乳酸纳米纤维膜的制造方法 | |
CN109174022B (zh) | 一种血液净化用吸附材料的固定化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiaojun Inventor after: Li Jing Inventor before: Huang Xiaojun Inventor before: Li Jing Inventor before: Xu Zhikang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG XIAOJUN LI JING XU ZHIKANG TO: HUANG XIAOJUN LI JING |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170707 Address after: 100723, No. 188, building 12, No. eight, South Fourth Ring Road, Fengtai District, Beijing, 5, 507 Patentee after: CIC Canton (Beijing) Technology Co., Ltd. Address before: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Patentee before: Zhejiang University |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170918 Address after: 214200 Jiangsu Province, Yixing city Yicheng Street Plaza Building 4 No. 118 grand sky Patentee after: Jiangsu able Membrane Technology Co., Ltd. Address before: 100723, No. 188, building 12, No. eight, South Fourth Ring Road, Fengtai District, Beijing, 5, 507 Patentee before: CIC Canton (Beijing) Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180518 Address after: 211800 Pukou District Garden idea 1, Nanjing, Jiangsu Patentee after: Nanjing Jia Lejing film Science and Technology Ltd. Address before: 214200 No. 4, Grand Hyatt Plaza, Yicheng street, Yixing, Jiangsu, 118 Patentee before: Jiangsu able Membrane Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210926 Address after: 215332 room 505, floor 5, building A12, No. 18, Jinxing Road, Huaqiao Town, Kunshan City, Suzhou City, Jiangsu Province Patentee after: Jiangsu Julan Nano Technology Co.,Ltd. Address before: 211800 Pukou District Garden idea 1, Nanjing, Jiangsu Patentee before: NANJING O'HAPPURE MEMBRANE TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220601 Address after: 224411 No. D-13, Chenji Town Industrial Park, Funing County, Yancheng City, Jiangsu Province Patentee after: Jiangsu juzhilan Technology Co.,Ltd. Address before: 215332 room 505, floor 5, building A12, No. 18, Jinxing Road, Huaqiao Town, Kunshan City, Suzhou City, Jiangsu Province Patentee before: Jiangsu Julan Nano Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |